- Home
- ATRA vs KRON Comparison
ATRA vs KRON Comparison
Compare ATRA & KRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATRA
- KRON
- Stock Information
- Founded
- ATRA 2012
- KRON 2017
- Country
- ATRA United States
- KRON United States
- Employees
- ATRA N/A
- KRON N/A
- Industry
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- KRON Medicinal Chemicals and Botanical Products
- Sector
- ATRA Health Care
- KRON Health Care
- Exchange
- ATRA Nasdaq
- KRON Nasdaq
- Market Cap
- ATRA 65.1M
- KRON 57.8M
- IPO Year
- ATRA 2014
- KRON 2020
- Fundamental
- Price
- ATRA $11.40
- KRON $0.96
- Analyst Decision
- ATRA Buy
- KRON Buy
- Analyst Count
- ATRA 6
- KRON 3
- Target Price
- ATRA $26.50
- KRON $1.63
- AVG Volume (30 Days)
- ATRA 77.5K
- KRON 379.1K
- Earning Date
- ATRA 11-12-2024
- KRON 11-13-2024
- Dividend Yield
- ATRA N/A
- KRON N/A
- EPS Growth
- ATRA N/A
- KRON N/A
- EPS
- ATRA N/A
- KRON N/A
- Revenue
- ATRA $100,439,000.00
- KRON $9,864,000.00
- Revenue This Year
- ATRA $1,346.63
- KRON $62.21
- Revenue Next Year
- ATRA N/A
- KRON N/A
- P/E Ratio
- ATRA N/A
- KRON N/A
- Revenue Growth
- ATRA 2111.34
- KRON 146.48
- 52 Week Low
- ATRA $6.50
- KRON $0.69
- 52 Week High
- ATRA $39.50
- KRON $1.60
- Technical
- Relative Strength Index (RSI)
- ATRA 51.71
- KRON 50.33
- Support Level
- ATRA $9.13
- KRON $0.91
- Resistance Level
- ATRA $13.64
- KRON $1.01
- Average True Range (ATR)
- ATRA 0.96
- KRON 0.06
- MACD
- ATRA -0.27
- KRON -0.01
- Stochastic Oscillator
- ATRA 50.33
- KRON 32.94
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).
About KRON Kronos Bio Inc.
Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine plan by targeting dysregulated transcription. The company operates in one business segment, the development of biopharmaceutical products.